DUSA Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- DUSA Pharmaceuticals's estimated annual revenue is currently $35.6M per year.
- DUSA Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- DUSA Pharmaceuticals has 177 Employees.
DUSA Pharmaceuticals's People
Name | Title | Email/Phone |
---|
DUSA Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 12 | -52% | N/A | N/A |
#4 | $25.7M | 128 | 39% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 51 | -14% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 249 | 3% | N/A | N/A |
What Is DUSA Pharmaceuticals?
Development Associates, a proprietorship formed in 1985 which provides consulting and venture support services to manage and finance early-stage technology-based companies DUSA Pharmaceuticals, Inc.® is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% photodynamic therapy (PDT) technology platform used in conjunction with it’s proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator. LEVULAN KERASTICK in combination with the BLU-U is approved by the U.S. Food and Drug Administration for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp
keywords:N/AN/A
Total Funding
177
Number of Employees
$35.6M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
DUSA Pharmaceuticals News
Dusa Pharmaceuticals; Novartis; Perrigo; Leo Pharma; Bausch Health; Taro Pharmaceutical; Galderma (nestle); Biofrontera; Almirall; Tolmar Pharmaceutical.
... Inc., LEO Pharma A/S, Mylan N.V., Novartis AG, Stanford Chemicals, and Sun Pharmaceutical Industries Ltd. (DUSA Pharmaceuticals, Inc.).
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $53.8M | 181 | -1% | N/A |
#2 | N/A | 181 | 45% | N/A |
#3 | $32M | 182 | 2% | N/A |
#4 | $42.5M | 184 | 28% | N/A |
#5 | $54.9M | 185 | 5% | N/A |